validation of the ipss-m risk stratification system in mds
Published 1 year ago • 57 plays • Length 3:57Download video MP4
Download video MP3
Similar videos
-
3:35
real-world validation of the value of the ipss-m for prognostication in patients with mds
-
1:40
mds 2023 highlights: classification and risk stratification systems & progression from ch to mds
-
2:01
updates in mds diagnosis and prognosis with the ipss-m: personalized medicine in 2023
-
0:58
risk stratification in mds
-
5:55
validation of non-invasive ai diagnostic tool for mds
-
3:22
performance of the aipss-mds ml model in predicting os & leukemic transformation in cmml
-
4:25
the challenges with accurately diagnosing and risk-stratifying patients with mds
-
4:28
understanding myelodysplastic syndromes (mds)
-
4:48
managing and treating mds
-
7:11
treatment of older mds patients with bmt (bone marrow transplantation)
-
1:16
state of the art: mds
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
11:53
the optimal treatment of lower risk mds
-
1:25
prognosis and treatment in high-risk mds
-
1:30
the prognostic value of patient-reported outcomes in mds
-
3:10
the role of ngs in mds diagnosis
-
1:26
current and emerging prognostic factors for mds/mpn
-
1:41
an overview of the mds diagnosis pathway
-
3:18
combining ogm with targeted ngs to improve the diagnosis and prognostication of mds
-
2:45
a personalized prediction model to risk stratify patients with mds
-
3:28
preclinical studies of tasquinimod in mds: in vitro and in vivo investigations